Supplier
ST. Marys Regional Health Center
ST. Marys Regional Health Center was paid $18.64M by Medicaid between Jan 2018 and Dec 2024, across 135 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 55% of everything it billed.
33Billing provider infoST. MARYS REGIONAL HEALTH CENTER
DETROIT LAKES, MN 56501
DETROIT LAKES, MN 56501
33aNPI1679561088assigned 10/10/2005
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$18.64M
24GClaims279,381
24DCodes billed135
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota
Rank by total paid#10 of 319
Median peer was paid$23K
This provider vs. median804×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HURLEY, ALAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,794 | $1.26M | |
| 2019 | 42,226 | $2.80M | |
| 2020 | 31,022 | $2.06M | |
| 2021 | 43,624 | $3.01M | |
| 2022 | 46,359 | $3.39M | |
| 2023 | 41,883 | $3.50M | |
| 2024incomplete | 30,473 | $2.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 55% | 117,691 | 99,955 | $10.20M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 19,062 | 16,058 | $2.63M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 12,086 | 10,249 | $2.17M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.4% | 15,886 | 13,385 | $1.57M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 2,427 | 2,155 | $287K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.3% | 2,490 | 2,425 | $249K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 33,621 | 29,213 | $225K |
| 80053 | Comprehensive metabolic panel | <1% | 12,208 | 11,073 | $120K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,328 | 1,210 | $106K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,755 | 2,695 | $105K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 1,822 | 1,230 | $86K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 422 | 386 | $68K |
123 more codes
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,819 | $56K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 555 | $48K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,194 | $46K |
| 73630 | <1% | 950 | $43K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,775 | $42K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,025 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,218 | $37K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,070 | $35K |
| 87631 | <1% | 372 | $35K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 276 | $28K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 235 | $28K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 622 | $26K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 178 | $22K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 183 | $21K |
| 71045 | Radiologic examination, chest; single view | <1% | 532 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 408 | $19K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,054 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,705 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 119 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 495 | $14K |
| 0002A | <1% | 456 | $13K | |
| 0001A | <1% | 450 | $13K | |
| 0240U | <1% | 81 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 488 | $11K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 117 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 411 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 210 | $8K |
| 81001 | <1% | 2,135 | $7K | |
| 84484 | <1% | 1,375 | $7K | |
| 90686 | <1% | 444 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 56 | $5K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 26 | $5K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,197 | $5K |
| 83605 | <1% | 1,275 | $5K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 18 | $5K |
| 83735 | <1% | 2,391 | $4K | |
| Q3014 | Telehealth originating site facility fee | <1% | 439 | $4K |
| 82746 | <1% | 399 | $4K | |
| 82728 | <1% | 411 | $4K | |
| 85027 | <1% | 1,563 | $4K | |
| 69210 | <1% | 84 | $4K | |
| 86140 | <1% | 981 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $3K |
| 96130 | <1% | 14 | $3K | |
| 82607 | <1% | 398 | $3K | |
| 0072A | <1% | 84 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 342 | $3K |
| 0071A | <1% | 85 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 132 | $2K |
| 87480 | <1% | 212 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,245 | $2K |
| 84703 | <1% | 881 | $2K | |
| 0004A | <1% | 109 | $2K | |
| 87634 | <1% | 82 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 30 | $2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 362 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 27 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 84 | $2K |
| 84481 | <1% | 267 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 45 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 365 | $1K |
| 90785 | <1% | 13 | $1K | |
| 87510 | <1% | 212 | $1K | |
| 0064A | <1% | 77 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $1K |
| 84439 | <1% | 297 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 69 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 771 | $1K |
| 82553 | <1% | 161 | $1K | |
| 86850 | <1% | 92 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 103 | $977.24 |
| J2704 | Injection, propofol, 10 mg | <1% | 492 | $972.38 |
| 80061 | Lipid panel | <1% | 92 | $929.46 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 561 | $890.43 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 69 | $882.18 |
| 82077 | <1% | 445 | $874.21 | |
| 87660 | <1% | 212 | $873.87 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 124 | $808.86 |
| 84425 | <1% | 114 | $752.81 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 149 | $681.84 |
| 0052A | <1% | 19 | $654.81 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 319 | $600.53 |
| 83655 | <1% | 43 | $599.96 | |
| 90662 | <1% | 38 | $557.53 | |
| 82550 | <1% | 195 | $556.70 | |
| 0054A | <1% | 18 | $555.03 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 275 | $547.90 |
| 0031A | <1% | 25 | $535.26 | |
| 86900 | <1% | 52 | $534.44 | |
| 85610 | <1% | 359 | $521.92 | |
| 85730 | <1% | 196 | $449.24 | |
| 81003 | <1% | 530 | $433.31 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 159 | $426.20 |
| 0051A | <1% | 12 | $426.09 | |
| 88142 | <1% | 58 | $400.93 | |
| 0012A | <1% | 20 | $338.75 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 244 | $299.01 |
| 98940 | <1% | 20 | $282.18 | |
| 86901 | <1% | 52 | $280.48 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 17 | $264.13 |
| 83690 | <1% | 169 | $225.69 | |
| 0011A | <1% | 18 | $218.79 | |
| 87081 | <1% | 160 | $206.09 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 14 | $164.15 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 14 | $147.96 |
| 82962 | <1% | 228 | $147.15 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 117 | $140.08 |
| 36416 | <1% | 100 | $111.85 | |
| 87040 | <1% | 44 | $105.10 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 41 | $85.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 13 | $39.82 |
| 85652 | <1% | 13 | $35.33 | |
| 80179 | <1% | 37 | $27.51 | |
| 80143 | <1% | 37 | $27.51 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 18 | $22.26 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $4.50 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 17 | $2.59 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 122 | $0.00 |
| 84100 | 0% | 46 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 15 | $0.00 |
| 96127 | 0% | 15 | $0.00 | |
| 83880 | 0% | 15 | $0.00 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHURLEY, ALAN (COO)
Parent organizationESSENTIA HEALTH
| Provider | Location | Paid |
|---|---|---|
| Innovis Health, LLC | Fargo, ND | $25.47M |
| ST Mary's Regional Health Center | Park Rapids, MN | $21.51M |
| ST Mary's Regional Health Center | Detroit Lakes, MN | $6.79M |
| Innovis Health LLC | Fargo, ND | $5.11M |
| Innovis Health LLC | Fargo, ND | $4.44M |
| ST Marys Regional Health Center | Park Rapids, MN | $4.26M |
| Bridges Medical Center | Ada, MN | $2.02M |
| ST Mary's Regional Health Center | Walker, MN | $1.86M |
| Graceville Health Center | Graceville, MN | $1.04M |
| Innovis Health, LLC. | Jamestown, ND | $990K |
| Innovis Health LLC | Moorhead, MN | $899K |
| Innovis Health LLC | Fargo, ND | $862K |
| ST Mary's Regional Health Center | Menahga, MN | $849K |
| ST Marys Regional Health Center | Detroit Lakes, MN | $806K |
| ST. Mary's Regional Health Center | Mahnomen, MN | $804K |
| Innovis Health LLC | Moorhead, MN | $795K |
| Innovis Health, LLC | Valley City, ND | $753K |
| Innovis Health, LLC | Bismarck, ND | $538K |
| Innovis Health, LLC. | Wahpeton, ND | $465K |
| ST. Mary's Regional Health Center | Pelican Rapids, MN | $459K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.